GO:0035910 ascending aorta morphogenesis: Developmental Process, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0035910 ascending aorta morphogenesis describes the developmental process that generates and organizes the anatomical structures of the ascending aorta, the segment between the heart and the aortic arch.
• Cardiac neural crest cells are essential for patterning the aortic arch arteries and outflow tract, and their disruption causes ascending aorta malformations.
• PAX genes, particularly PAX3 and PAX7, are expressed in neural crest-derived mesenchyme and regulate cardiovascular development, including aortic arch artery remodeling.
• Fetal hemodynamics, including blood flow velocity and vessel diameter, influence ascending aorta growth and can be assessed prenatally; dilated ascending aorta in the fetus is a detectable phenotype.
• Perivascular lymphatic vessels and immune cell mobilization protect against thoracic aortic dissection, linking ascending aorta morphogenesis to adult vascular pathology.
• Research on ascending aorta morphogenesis uses knockout, knock-in, and overexpression models, combined with imaging, transcriptomics, and lineage tracing to dissect gene function.
Description
The ascending aorta is the portion of the aorta that arises from the heart and extends to the aortic arch, playing a critical role in systemic circulation. Its morphogenesis, defined by GO:0035910, encompasses the coordinated cellular and molecular events that generate and organize this vessel during embryonic development. Understanding this process is fundamental to developmental biology and cardiovascular medicine because defects in ascending aorta formation can lead to congenital heart defects, aortic aneurysms, and dissections. The cardiac neural crest contributes significantly to the remodeling of the aortic arch arteries and outflow tract, and perturbations in neural crest cell migration or differentiation result in aortic malformations. Additionally, PAX genes are key regulators of cardiovascular development, with PAX3 and PAX7 expressed in neural crest-derived tissues that contribute to the aorta. Fetal hemodynamic forces also shape the ascending aorta, and abnormal flow patterns can result in dilation detectable by prenatal ultrasound. Recent studies highlight the protective role of periaortic lymphatic vessels and immune responses in preventing thoracic aortic dissection, underscoring the clinical relevance of ascending aorta morphogenesis beyond embryogenesis. This article synthesizes current knowledge on the molecular and cellular mechanisms, key genes, and experimental models used to study GO:0035910, providing a resource for researchers and clinicians.
ascending aorta morphogenesis At A Glance
| GO ID | GO:0035910 |
|---|---|
| GO term | ascending aorta morphogenesis |
| Ontology | biological_process |
| Synonym | None |
| Major function | Generation and organization of the anatomical structures of the ascending aorta, including its wall and lumen, during development |
| Related processes | Cardiac neural crest cell migration and differentiation, aortic arch artery remodeling, outflow tract septation, hemodynamic force sensing |
| Key cell types | Cardiac neural crest cells, endothelial cells, vascular smooth muscle cells, fibroblasts |
| Developmental timing | Embryonic to fetal stages, with ongoing remodeling in early postnatal life |
| Clinical relevance | Congenital aortic malformations, aortic aneurysm, aortic dissection, dilated ascending aorta in fetuses |
What Is GO:0035910?
GO:0035910 ascending aorta morphogenesis is the biological process in which the anatomical structures of the ascending aorta are generated and organized. The ascending aorta is the segment of the aorta in a two-pass circulatory system that lies between the heart and the arch of the aorta. In a two-pass circulatory system, blood passes twice through the heart to supply the body once. This process includes the specification, migration, proliferation, and differentiation of cells that form the aortic wall, as well as the remodeling of the aortic arch arteries and outflow tract to establish a functional ascending aorta.
Why Is ascending aorta morphogenesis Important in Cell Biology?
Ascending aorta morphogenesis is critical because the ascending aorta is the primary conduit for oxygenated blood from the left ventricle to the systemic circulation. Disruptions in this process can cause life-threatening congenital defects such as interrupted aortic arch, coarctation, and aortic valve anomalies, as well as predispose to aortic aneurysm and dissection later in life. Understanding the genetic and cellular mechanisms governing ascending aorta morphogenesis is essential for developing diagnostic markers and therapeutic strategies for these conditions. Moreover, insights from developmental biology inform tissue engineering approaches for aortic repair and regeneration.
• Congenital heart defects: Abnormal cardiac neural crest development leads to outflow tract and aortic arch malformations, including persistent truncus arteriosus and interrupted aortic arch.
• Aortic aneurysm and dissection: Defects in ascending aorta wall integrity can result in thoracic aortic aneurysm and dissection, with recent evidence linking periaortic lymphatic vessels and immune responses to protection against dissection.
• Fetal diagnosis: Dilated ascending aorta can be detected prenatally by ultrasound, and hemodynamic parameters such as flow velocity are used to assess fetal cardiovascular health.
• Genetic regulation: PAX genes, particularly PAX3 and PAX7, are expressed in neural crest-derived mesenchyme and are essential for cardiovascular development, including aortic arch artery remodeling.
• Hemodynamic forces: Blood flow patterns influence ascending aorta growth and remodeling; altered hemodynamics can lead to vessel dilation or malformation.
• Tissue engineering: Knowledge of ascending aorta morphogenesis guides the design of biomimetic grafts and regenerative therapies for aortic diseases.
• Model organisms: Mouse, chick, and zebrafish models have been instrumental in identifying signaling pathways and cell lineages involved in ascending aorta formation.
• Translational research: Identifying molecular players in ascending aorta morphogenesis provides candidate targets for pharmacological intervention in aortic diseases.
What Happens During ascending aorta morphogenesis?
Specification and migration of cardiac neural crest cells
In simple terms: Specialized embryonic cells called cardiac neural crest cells move to the heart region to help build the aorta.
Cardiac neural crest cells originate from the dorsal neural tube and migrate to the pharyngeal arches and outflow tract, where they contribute to the septation of the truncus arteriosus and the remodeling of the aortic arch arteries. These cells are essential for the formation of the ascending aorta and its associated structures; their ablation or misregulation results in severe aortic arch anomalies.
Remodeling of the pharyngeal arch arteries
In simple terms: The early blood vessels in the throat region are reshaped into the final aorta and its branches.
The pharyngeal arch arteries (also called aortic arch arteries) undergo asymmetric remodeling to form the definitive aortic arch and its branches. The ascending aorta derives primarily from the outflow tract and the fourth pharyngeal arch artery. Signaling pathways including Notch, TGF-beta, and VEGF regulate endothelial cell proliferation, apoptosis, and smooth muscle cell recruitment during this remodeling.
Outflow tract septation and alignment
In simple terms: The single tube leaving the heart is divided into two separate vessels, the aorta and the pulmonary artery.
Conotruncal septation divides the common outflow tract into the ascending aorta and the pulmonary trunk. This process requires the coordinated interaction of cardiac neural crest cells, endocardium, and myocardium. Defects in septation lead to persistent truncus arteriosus or transposition of the great arteries, conditions that affect the ascending aorta.
Hemodynamic forces and vessel growth
In simple terms: Blood flow pushes on the vessel walls, helping them grow and shape correctly.
After the initial patterning, hemodynamic forces such as shear stress and circumferential stretch influence the growth and remodeling of the ascending aorta. Fetal echocardiography studies show that blood flow velocity and vessel diameter are correlated with ascending aorta dimensions, and abnormal flow can lead to dilation. Endothelial cells sense these forces and transduce signals that modulate extracellular matrix production and smooth muscle cell phenotype.
Perivascular lymphatic and immune interactions
In simple terms: Lymphatic vessels and immune cells around the aorta help protect it from damage.
Recent studies have identified periaortic lymphatic vessels as important players in maintaining aortic wall integrity. Activation of beta3-adrenergic receptors promotes lymphangiogenesis in perivascular adipose tissue, which prevents aortic dissection and aneurysm. Additionally, periaortic lymphatic vessels mobilize immune responses that protect against thoracic aortic dissection. These findings link ascending aorta morphogenesis and homeostasis to lymphatic and immune system functions.
Key Genes Involved in GO:0035910 ascending aorta morphogenesis
The following genes have been experimentally implicated in ascending aorta morphogenesis and related cardiovascular development.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PAX3 | Neural crest cell migration and differentiation; cardiovascular development | Knockout causes outflow tract and aortic arch defects; studied in neural crest lineages |
| PAX7 | Neural crest-derived mesenchyme; skeletal muscle and cardiovascular development | Expressed in cardiac neural crest; potential role in aortic arch artery remodeling |
| NOTCH1 | Endothelial-to-mesenchymal transition; outflow tract septation | Mutations linked to bicuspid aortic valve and ascending aortic aneurysm |
| TGFBR2 | TGF-beta signaling; smooth muscle cell differentiation | Mutations cause Loeys-Dietz syndrome with ascending aortic aneurysm |
| FBN1 | Extracellular matrix structural component; elastic fiber assembly | Mutations cause Marfan syndrome with ascending aortic dilation and dissection |
| ACTA2 | Smooth muscle cell contractility; aortic wall integrity | Mutations associated with familial thoracic aortic aneurysm and dissection |
| MYH11 | Smooth muscle myosin heavy chain; contractile function | Mutations linked to thoracic aortic aneurysm |
| COL3A1 | Type III collagen; extracellular matrix strength | Mutations cause vascular Ehlers-Danlos syndrome with aortic rupture |
| VEGFA | Angiogenesis; endothelial cell survival and proliferation | Regulates aortic arch artery remodeling |
| SEMA3C | Semaphorin signaling; neural crest cell migration | Knockout leads to outflow tract and aortic arch defects |
| PLEXIN A2 | Semaphorin receptor; neural crest guidance | Mutations associated with aortic arch anomalies |
| TBX1 | Transcription factor; pharyngeal arch development | Deletion causes DiGeorge syndrome with aortic arch defects |
| GATA6 | Transcription factor; outflow tract and aortic development | Mutations linked to congenital heart defects including aortic anomalies |
| MEF2C | Transcription factor; cardiac neural crest and smooth muscle | Required for aortic arch artery remodeling |
| SOX9 | Neural crest stem cell maintenance; cartilage and vascular development | Involved in outflow tract and aortic valve formation |
| ADRB3 | Beta3-adrenergic receptor; lymphangiogenesis in perivascular adipose tissue | Activation prevents aortic dissection/aneurysm |
| PROX1 | Lymphatic endothelial cell fate; lymphatic vessel development | Periaortic lymphatic vessels protect against aortic dissection |
How Is ascending aorta morphogenesis Regulated?
Ascending aorta morphogenesis is regulated by a complex interplay of genetic and environmental factors. Key signaling pathways include Notch, TGF-beta, VEGF, and semaphorin-plexin signaling, which control neural crest cell migration, endothelial-to-mesenchymal transition, and smooth muscle cell differentiation. Hemodynamic forces act as mechanical regulators, modulating gene expression in endothelial cells and influencing vessel wall remodeling. Recent studies have identified beta3-adrenergic receptor signaling as a regulator of lymphangiogenesis in perivascular adipose tissue, which in turn protects against aortic dissection. Additionally, immune cell mobilization via periaortic lymphatic vessels contributes to aortic wall homeostasis. These regulatory mechanisms are potential targets for therapeutic intervention in aortic diseases.
ascending aorta morphogenesis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| FBN1 | Marfan syndrome; thoracic aortic aneurysm and dissection | Knock-in mouse models with patient mutations; smooth muscle cell-specific knockout |
| TGFBR2 | Loeys-Dietz syndrome; aortic aneurysm | Conditional knockout in neural crest or smooth muscle cells |
| ACTA2 | Familial thoracic aortic aneurysm and dissection | Knock-in mice expressing mutant ACTA2; vascular smooth muscle cell overexpression |
| ADRB3 | Aortic dissection/aneurysm; lymphangiogenesis | Agonist treatment in mouse models; knockout of Adrb3 |
| PROX1 | Thoracic aortic dissection; lymphatic vessel function | Lymphatic-specific knockout; periaortic lymphatic imaging |
Congenital heart defects and aortic arch anomalies
Disruptions in cardiac neural crest cell development cause a spectrum of congenital heart defects, including interrupted aortic arch, coarctation of the aorta, and persistent truncus arteriosus. These conditions often require surgical correction in infancy and are associated with significant morbidity. PAX genes, such as PAX3, are critical for neural crest function, and their dysregulation can lead to aortic arch malformations.
Thoracic aortic aneurysm and dissection
Defects in the structural integrity of the ascending aorta can lead to thoracic aortic aneurysm and dissection. Mutations in genes such as FBN1, TGFBR2, ACTA2, and MYH11 are well-known causes of familial aortic disease. Recent research has shown that periaortic lymphatic vessels and immune responses play protective roles; activation of beta3-adrenergic receptors promotes lymphangiogenesis and prevents aortic dissection in animal models. Similarly, mobilization of immune responses by periaortic lymphatic vessels protects against thoracic aortic dissection.
Fetal dilated ascending aorta
Dilation of the ascending aorta can be detected prenatally by fetal echocardiography. A study of fetuses with dilated ascending aorta found associations with various cardiac and extracardiac anomalies, and highlighted the importance of hemodynamic assessment. Fetal hemodynamics, including flow velocity and vessel diameter, are key parameters in evaluating ascending aorta growth.
From ascending aorta morphogenesis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate cardiac neural crest migration? | Neural crest-specific Cre driver (e.g., Wnt1-Cre) combined with conditional knockout of gene X in mouse |
| Does a point mutation in gene Y cause ascending aorta dilation? | Knock-in mouse expressing the patient mutation; echocardiography to measure aortic diameter |
| What is the role of gene Z in endothelial-to-mesenchymal transition? | Endothelial-specific knockout or overexpression; lineage tracing with Tie2-Cre |
| Does overexpression of gene W rescue aortic arch defects? | Transgenic overexpression in neural crest cells; rescue experiments in knockout background |
| How does hemodynamic force affect ascending aorta remodeling? | Zebrafish or mouse models with altered blood flow; in vitro shear stress systems |
| What is the impact of gene V on periaortic lymphangiogenesis? | Lymphatic endothelial cell-specific knockout; whole-mount immunofluorescence of periaortic vessels |
How to Study the ascending aorta morphogenesis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Lineage tracing (Cre-loxP) | Cell fate and contribution to aortic structures | Tracking neural crest and endothelial cell lineages in mouse embryos |
| Fetal echocardiography | Ascending aorta diameter, flow velocity, and cardiac function | Prenatal diagnosis of aortic dilation and hemodynamic assessment |
| Single-cell RNA-seq | Transcriptional profiles of individual cells | Identifying cell types and gene expression programs in developing aorta |
| Micro-CT | 3D anatomical structure of the aorta and branches | Quantifying aortic arch remodeling in mouse models |
| Immunofluorescence | Protein localization and cell type markers | Visualizing smooth muscle, endothelial, and lymphatic markers in aortic tissue |
| CRISPR-Cas9 knockout | Gene function loss | Generating mouse or cell models to test candidate genes |
| In situ hybridization | Spatial gene expression patterns | Detecting mRNA of key genes (e.g., Pax3, Tbx1) in developing aorta |
| Western blot | Protein expression and signaling activation | Validating pathway activity (e.g., TGF-beta, Notch) in aortic tissues |
Lineage tracing and genetic fate mapping
Lineage tracing using Cre-loxP systems allows researchers to follow the fate of cardiac neural crest cells and other progenitors during ascending aorta morphogenesis. For example, Wnt1-Cre or Pax3-Cre drivers can label neural crest cells, and their contribution to the aortic wall can be visualized with reporter genes. This method is essential for understanding the cellular origins of aortic structures.
Imaging and morphometrics
High-resolution imaging techniques such as optical coherence tomography, micro-CT, and confocal microscopy enable detailed visualization of the developing aorta in model organisms. Fetal echocardiography in humans and mice provides non-invasive assessment of ascending aorta diameter and flow dynamics. These methods are critical for phenotyping aortic malformations.
Transcriptomics and single-cell RNA sequencing
RNA sequencing of sorted cell populations or single cells from the developing aorta can identify gene expression programs and signaling pathways active during morphogenesis. This approach has revealed heterogeneity among neural crest-derived cells and smooth muscle cells, and can uncover novel regulators of ascending aorta development.
Functional perturbation with CRISPR and transgenesis
CRISPR-Cas9 genome editing enables the generation of knockout, knock-in, and point-mutation models to test gene function in ascending aorta morphogenesis. Combined with transgenic overexpression or conditional alleles, these tools allow precise dissection of molecular mechanisms in vivo.
How CRISPR Can Be Used to Study GO:0035910 ascending aorta morphogenesis
Knockout
CRISPR-Cas9 knockout of candidate genes in mouse models or cell lines is a powerful approach to determine their requirement for ascending aorta morphogenesis. For example, knockout of Pax3 or Tbx1 recapitulates aortic arch defects observed in human syndromes. Conditional knockout using Cre-loxP allows tissue-specific deletion to avoid early lethality.
Point Mutation
Introducing precise point mutations via CRISPR-Cas9 homology-directed repair or base editing enables modeling of human disease variants. For instance, knock-in of ACTA2 or TGFBR2 mutations associated with thoracic aortic aneurysm allows study of their effects on aortic wall integrity and smooth muscle function.
Knock-in
Knock-in of reporter genes (e.g., GFP, lacZ) or epitope tags into endogenous loci facilitates lineage tracing and protein localization studies. Tagging endogenous proteins with fluorescent markers allows real-time imaging of their dynamics during ascending aorta development.
Overexpression
CRISPR activation (CRISPRa) or transgenic overexpression can be used to test gain-of-function effects of genes in ascending aorta morphogenesis. For example, overexpression of Vegfa or Notch ligands in neural crest cells can perturb aortic arch remodeling, providing insights into dosage-sensitive pathways.
How EDITGENE Supports ascending aorta morphogenesis Research
Researchers studying ascending aorta morphogenesis-related genes often need to determine whether a candidate gene is causally involved in the process or merely correlated with it. This requires precise genetic models that can knock out, mutate, or overexpress the gene of interest in relevant cell types. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate such discoveries.
Contact EDITGENE today to design your custom CRISPR model for ascending aorta morphogenesis research.
Frequently Asked Questions About ascending aorta morphogenesis
What is GO:0035910 ascending aorta morphogenesis?
GO:0035910 is a Gene Ontology biological process term that describes the generation and organization of the anatomical structures of the ascending aorta, the vessel segment between the heart and the aortic arch.
What genes are involved in ascending aorta morphogenesis?
Key genes include cardiac neural crest regulators such as PAX3 and PAX7, signaling molecules like NOTCH1, TGFBR2, and VEGFA, and structural components such as FBN1, ACTA2, and MYH11.
How does the cardiac neural crest contribute to ascending aorta formation?
Cardiac neural crest cells migrate to the outflow tract and pharyngeal arches, where they are essential for septation of the truncus arteriosus and remodeling of the aortic arch arteries into the ascending aorta.
What diseases are associated with defective ascending aorta morphogenesis?
Defects can cause congenital heart defects like interrupted aortic arch, as well as thoracic aortic aneurysm and dissection, often linked to mutations in FBN1, TGFBR2, ACTA2, and other genes.
How is ascending aorta morphogenesis studied in animal models?
Researchers use mouse, chick, and zebrafish models with lineage tracing, conditional knockouts, and imaging to visualize neural crest migration, aortic arch remodeling, and hemodynamic effects.
What is the role of hemodynamics in ascending aorta development?
Blood flow forces such as shear stress influence endothelial cell gene expression and vessel wall remodeling; abnormal flow can lead to ascending aorta dilation, detectable by fetal echocardiography.
Can CRISPR be used to study ascending aorta morphogenesis?
Yes, CRISPR-Cas9 enables knockout, knock-in, and point mutation models in mice and cell lines to test gene function in aortic development and disease.
What are periaortic lymphatic vessels and how do they relate to aortic dissection?
Periaortic lymphatic vessels are lymphatic networks surrounding the aorta that help maintain aortic wall integrity; their activation via beta3-adrenergic receptors or immune mobilization protects against thoracic aortic dissection.
What is the clinical significance of a dilated ascending aorta in fetuses?
Fetal dilation of the ascending aorta can be associated with cardiac and extracardiac anomalies and may indicate underlying hemodynamic or genetic disorders, warranting careful prenatal evaluation.
Which signaling pathways regulate ascending aorta morphogenesis?
Major pathways include Notch, TGF-beta, VEGF, and semaphorin-plexin signaling, which control neural crest cell behavior, endothelial-to-mesenchymal transition, and smooth muscle differentiation.
Conclusion
GO:0035910 ascending aorta morphogenesis is a complex developmental process essential for establishing the major outflow vessel of the heart. It involves the coordinated action of cardiac neural crest cells, endothelial cells, and smooth muscle cells, guided by genetic programs and hemodynamic forces. Disruptions in this process lead to congenital aortic malformations and predispose to life-threatening aneurysms and dissections. Ongoing research using advanced CRISPR models and imaging techniques continues to uncover new molecular players, such as periaortic lymphatic regulators, offering hope for novel therapeutic strategies. EDITGENE supports this research with comprehensive gene editing and screening services to accelerate discoveries in aortic biology.
References
- 1. Yamagishi H. 2021. Cardiac Neural Crest.. Cold Spring Harb Perspect Biol 13(1) PMID: 32071091
- 2. Dumitrascu-Biris I et al.. 2021. Dilated ascending aorta in the fetus.. Prenat Diagn 41(9):1127-1133 PMID: 34212413
- 3. Zhang ZB et al.. 2024. Activation of β3-adrenergic receptor by mirabegron prevents aortic dissection/aneurysm by promoting lymphangiogenesis in perivascular adipose tissue.. Cardiovasc Res 120(17):2307-2319 PMID: 39288197
- 4. Pei Y et al.. 2025. Periaortic lymphatic vessels protect against thoracic aortic dissection through mobilizing immune response.. Cardiovasc Res 121(16):2594-2609 PMID: 41213294
- 5. Brezinka C. 2001. Fetal hemodynamics.. J Perinat Med 29(5):371-80 PMID: 11723838
- 6. Steele RE et al.. 2022. PAX Genes in Cardiovascular Development.. Int J Mol Sci 23(14) PMID: 35887061
- 7. Miquerol L et al.. 2013. Organogenesis of the vertebrate heart.. Wiley Interdiscip Rev Dev Biol 2(1):17-29 PMID: 23799628
- 8. Rothenberg F et al.. 2003. Sculpting the cardiac outflow tract.. Birth Defects Res C Embryo Today 69(1):38-45 PMID: 12768656
